American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about PaySign, Inc. (NASDAQ:PAYS) Insider Topline Capital Management, Ll Acquires 54,183 Shares

PaySign, Inc. (NASDAQ:PAYS) Insider Topline Capital Management, Ll Acquires 54,183 Shares

PaySign, Inc. (NASDAQ:PAYS – Get Free Report) insider Topline Capital Management, Ll purchased 54,183 shares of the business’s stock in a transaction on Friday, March 15th. The shares were purchased at an average price... More of this article »
Image about Symbotic Inc. (NASDAQ:SYM) Director Merline Saintil Sells 3,135 Shares of Stock

Symbotic Inc. (NASDAQ:SYM) Director Merline Saintil Sells 3,135 Shares of Stock

Symbotic Inc. (NASDAQ:SYM – Get Free Report) Director Merline Saintil sold 3,135 shares of the stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $44.74, for a total transaction of... More of this article »
Image about Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano Sells 923 Shares of Stock

Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano Sells 923 Shares of Stock

Zoetis Inc. (NYSE:ZTS – Get Free Report) EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $173.33, for a total value of $159,983.59.... More of this article »
Image about Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $9.00 at HC Wainwright

Aquestive Therapeutics (NASDAQ:AQST) Price Target Raised to $9.00 at HC Wainwright

Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its price objective lifted by HC Wainwright from $7.00 to $9.00 in a research report sent to investors on Monday morning, Benzinga reports. HC Wainwright currently has a... More of this article »
Image about SkyWest, Inc. (NASDAQ:SKYW) Director James L. Welch Sells 2,000 Shares of Stock

SkyWest, Inc. (NASDAQ:SKYW) Director James L. Welch Sells 2,000 Shares of Stock

SkyWest, Inc. (NASDAQ:SKYW – Get Free Report) Director James L. Welch sold 2,000 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $66.72, for a total transaction of $133,440.00.... More of this article »
Image about Eaton (NYSE:ETN) Price Target Raised to $330.00 at Bank of America

Eaton (NYSE:ETN) Price Target Raised to $330.00 at Bank of America

Eaton (NYSE:ETN – Free Report) had its target price hoisted by Bank of America from $320.00 to $330.00 in a research note released on Monday morning, Benzinga reports. The firm currently has a buy rating on the industrial products... More of this article »
Image about Princeton Bancorp, Inc. (NASDAQ:BPRN) Director Martin Tuchman Purchases 5,000 Shares of Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN) Director Martin Tuchman Purchases 5,000 Shares of Stock

Princeton Bancorp, Inc. (NASDAQ:BPRN – Get Free Report) Director Martin Tuchman purchased 5,000 shares of the business’s stock in a transaction on Friday, March 15th. The shares were purchased at an average price of $29.74... More of this article »
Image about Blend Labs (NYSE:BLND) Given New $3.00 Price Target at Canaccord Genuity Group

Blend Labs (NYSE:BLND) Given New $3.00 Price Target at Canaccord Genuity Group

Blend Labs (NYSE:BLND – Free Report) had its target price upped by Canaccord Genuity Group from $2.00 to $3.00 in a report released on Monday morning, Benzinga reports. The brokerage currently has a hold rating on the stock. Separately,... More of this article »
Image about Cipher Mining’s (CIFR) Buy Rating Reaffirmed at Needham & Company LLC

Cipher Mining’s (CIFR) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Cipher Mining (NASDAQ:CIFR – Free Report) in a research report sent to investors on Monday, Benzinga reports. Needham & Company LLC currently has a $5.00... More of this article »
Image about EOG Resources (NYSE:EOG) Price Target Increased to $124.00 by Analysts at Citigroup

EOG Resources (NYSE:EOG) Price Target Increased to $124.00 by Analysts at Citigroup

EOG Resources (NYSE:EOG – Free Report) had its price target increased by Citigroup from $120.00 to $124.00 in a report issued on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the energy exploration... More of this article »
Image about Celsius (NASDAQ:CELH) Given New $95.00 Price Target at Stifel Europe

Celsius (NASDAQ:CELH) Given New $95.00 Price Target at Stifel Europe

Celsius (NASDAQ:CELH – Free Report) had its price objective boosted by Stifel Europe from $90.00 to $95.00 in a research note issued to investors on Monday morning. Stifel Europe currently has a buy rating on the stock. CELH... More of this article »
Image about Black Diamond Therapeutics (NASDAQ:BDTX) Given Buy Rating at HC Wainwright

Black Diamond Therapeutics (NASDAQ:BDTX) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a research note published on Monday, Benzinga reports. The firm currently has a $12.00 price target on the stock,... More of this article »
Image about ASLAN Pharmaceuticals (NASDAQ:ASLN) Given New $9.00 Price Target at HC Wainwright

ASLAN Pharmaceuticals (NASDAQ:ASLN) Given New $9.00 Price Target at HC Wainwright

ASLAN Pharmaceuticals (NASDAQ:ASLN – Free Report) had its target price reduced by HC Wainwright from $17.00 to $9.00 in a report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. ASLAN... More of this article »
Image about LegalZoom.com, Inc. (NASDAQ:LZ) COO Richard Preece Sells 9,462 Shares of Stock

LegalZoom.com, Inc. (NASDAQ:LZ) COO Richard Preece Sells 9,462 Shares of Stock

LegalZoom.com, Inc. (NASDAQ:LZ – Get Free Report) COO Richard Preece sold 9,462 shares of LegalZoom.com stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $13.17, for a total transaction... More of this article »
Image about Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Downgraded by StockNews.com

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Downgraded by StockNews.com

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday. Separately, B. Riley... More of this article »